Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1474 | Pituitary Clinical | ICEECE2012

Long-term outcomes after sterotactic radiosurgery for non-functioning pituitary adenomas

Suleiman Y , Vilchez R , Roman A , Soto A , Venegas E , Soto A , Atutxa A , Martin J , Torres E

Introduction: Sterotactic radiosurgery (SR) has been used to treat recurrent adenomas and also as a primary treatment. The objective is to evaluate long-term tumor control, development of hypopituitarism and other side effects in the follow-up.Patients and method: Retrospective analysis of 21 patients with non-functioning pituitary adenomas (NFA) treated with modified linear accelerator (LINAC) between 1998 and 2009 in three tertiary Spanish hospitals. C...

ea0029p1475 | Pituitary Clinical | ICEECE2012

Long-term outcomes after sterotactic radiosurgery for functioning pituitary adenomas

Suleiman Y , Vilchez R , Roman A , Soto A , Venegas E , Leal A , Atutxa A , Martin J , Torres E

Introduction: Sterotactic radiosurgery (SR) has been used to treat recurrent adenomas after failure of medical and surgical procedures and also as a primary treatment. The aim of this paper is to evaluate long-term control of functioning pituitary adenomas (FPA).Patients and method: Thirty-eight patients with FPA treated with modified linear accelerator (LINAC) between 1998 and 2009 in three tertiary Spanish hospitals. Hormonal control was defined as hor...

ea0037ep701 | Pituitary: basic and neuroendocrinology | ECE2015

Clinical and molecular differences between invasive and non-invasive pituitary adenomas

Cano David , Mendez-Muros Mariola , Venegas-Moreno Eva Maria , Gros Noelia , Dios Elena , Garcia-Hernandez Natividad , Madrazo-Atutxa Ainara , Martin Ignacio , Cardenas Eugenio , Kaen Ariel , Roldan Florinda , Soto-Moreno Alfonso

Pituitary adenomas are usually benign. However, a significant number of pituitary adenomas show an aggressive behaviour, with local invasion, increased risk of recurrence after surgery and lack of therapeutic response. In this study, we aimed to determine whether invasive and non-invasive pituitary adenomas display differences in clinical features and molecular parameters. In this retrospective descriptive study, 46 pituitary adenomas were analysed. Invasiveness was defined as...

ea0070aep684 | Pituitary and Neuroendocrinology | ECE2020

Evaluation of somatostatin and dopamine receptor expression in nonfunctioning pituitary adenomas

Cano Gonzales David , Flores-Martinez Alvaro , Venegas Moreno Eva , Dios Elena , Remon Pablo , Deniz-Ruiz Alejandro , Madrazo-Atutxa Ainara , Luque Raul M. , Castaño Justo P. , Soto-Moreno Alfonso

Introduction: Non-functioningpituitary adenomas (NFPAs) are of benign nature but a sizeable number of NFPAs show aggressive features. Surgery is not always effective in treating NFPAs and thus other therapeutic options are needed. Previous studies have reported that NFPAs express somastostatin receptors (SSTRs) and dopamine receptors (DRDs).Aim: To systematically analyze the expression of SSTRs and DRDs in a large cohort of clinically well-characterized ...

ea0056gp196 | Pituitary Basic | ECE2018

E-cadherin expression is associated with the response to somatostatin analogues in patients with acromegaly

Cano David A , Venegas-Moreno Eva , Gros-Herguido Noelia , Dios Elena , Flores-Martinez Alvaro , Gonzalez Natividad , Madrazo-Atutxa Ainara , Cardenas Eugenio , Kaen Ariel , Castano Justo P , Luque Raul M , Soto-Moreno Alfonso

Aim: To assess whether E-cadherin expression levels in somatotropinomas were associated with the response to somatostatin analogues (SSAs) therapy in patients with acromegaly.Methods: In this retrospective study, 56 acromegaly patients that underwent transsphenoidal surgery were evaluated. All patients were treated preoperatively with SSAs (octreotide or lanreotide) for at least 6 months. Responsiveness to SSAs was evaluated by percent IGF-1 reduction af...

ea0032p696 | Neuroendocrinology | ECE2013

Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population

Leal-Cerro Alfonso , Madrazo-Atutxa Ainara , Garcia-Arnes Juan , Lamas-Oliveira Cristina , Boronat-Cort Mauro , Lillo Juan A , Fajardo Carmen , Urgell-Rull Eulalia , Salvador Javier , Salinas Isabel , Bernabeu Ignacio , Paramo Concha , Webb Susan , Torres-Vela Elena , Diaz Angel , Aller Javier , Leon-Justel Antonio

Introduction: Endogenous Cushing’s syndrome (CS) is a rare, infradiagnosed and severe disease that carries high morbidity and mortality. Delays in treatment initiation reduce reversibility of symptoms and increase mortality rate. Current gold standard for screening, 24 h urinary free cortisol, has a low reproducibility and specificity, and sampling is complicated. Midnight salivary cortisol (MSVC) determination is considered an easy and cheap test. We intend to assess its...